-+ 0.00%
-+ 0.00%
-+ 0.00%
enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiency
Share
Listen to the news
enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiency
  • enVVeno Medical received FDA IDE clearance for a U.S. pivotal study of its enVVe bioprosthetic venous valve system.
  • TAVVE trial slated to start in Q4 2026; targets about 230 patients at up to 40 U.S. sites.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enVVeno Medical Corp. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608270901ACCESSWRNAPR_____1213053) on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending